Sontag Advisory »

Galmed Pharmaceuticals shares owned by Sontag Advisory

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $29 21 1.38

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Galmed Pharmaceuticals

Citadel Advisors
Morgan Stanley
Two Sigma Investments
UBS Group
Sontag Advisory
TSFG
SBI Securities
Federation des caisses Desjardins du Quebec
Wells Fargo & Company
Advisor Group Holdings
Hanson McClain Advisors
TD Waterhouse Canada
Dogwood Wealth Management
Zrc Wealth Management

View all funds holding Galmed Pharmaceuticals